IMUNAMI LABORATORIES PTE LTD has a total of 13 patent applications. It decreased the IP activity by 33.0%. Its first patent ever was published in 2017. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals and biotechnology are OUTLOOK THERAPEUTICS INC, CHAKRABARTY ANANDA and BEIJING TRI PRIME GENETIC ENG.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | WIPO (World Intellectual Property Organization) | 2 | |
#3 | Australia | 1 | |
#4 | Canada | 1 | |
#5 | China | 1 | |
#6 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Chen Ya-Huei | 13 |
#2 | Lin Ting-Long | 13 |
Publication | Filing date | Title |
---|---|---|
US10675332B1 | Recombinant polypeptides and methods of use thereof | |
WO2021040610A1 | Recombinant polypeptides and methods of use thereof | |
AU2017444998A1 | Recombinant polypeptides and methods of use thereof | |
US10150801B1 | Recombinant polypeptides and methods of use thereof |